Schrödinger Balance Sheet Health
Financial Health criteria checks 6/6
Schrödinger has a total shareholder equity of $474.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $688.4M and $214.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$377.29m |
| Equity | US$473.98m |
| Total liabilities | US$214.39m |
| Total assets | US$688.37m |
Recent financial health updates
Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation
Aug 05
We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow
Nov 12Recent updates
Schrodinger: More Drug Discovery Validation
Aug 06Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation
Aug 05We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right
Jun 12Schrödinger: More Pharmaceutical Than Software
May 07Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar
May 02Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially
Mar 01Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024
Mar 01Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Feb 28The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%
Feb 01Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable
Dec 18Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?
Sep 28Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?
Jul 01Schrödinger: Q2 Earnings Supports Growth Narrative
Aug 26Schrödinger appoints Dr. Geoffrey Porges as finance chief
Aug 18Sizing Up Schrodinger
Jun 06Schrödinger: Holding The Keys To Discovery
Mar 26Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too
Mar 15Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be Critical
Jan 06After Its Stock Price Doubled Last Year, Why Schrödinger Is Slumping Now
Nov 24We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow
Nov 12An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 38% Undervalued
Oct 05Schrodinger: An Investment In Drug Discovery In Addition To Software Sales
Sep 20Financial Position Analysis
Short Term Liabilities: SDGR's short term assets ($449.2M) exceed its short term liabilities ($99.8M).
Long Term Liabilities: SDGR's short term assets ($449.2M) exceed its long term liabilities ($114.6M).
Debt to Equity History and Analysis
Debt Level: SDGR is debt free.
Reducing Debt: SDGR has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SDGR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SDGR has sufficient cash runway for 3 years if free cash flow continues to reduce at historical rates of 40.9% each year.